Skip to main content
Caplight Logo









Resistell AG

Resistell AG

Private
MuttenzHealthcare & Life Scienceshttps://resistell.com/

Last Round

Grant

Jan 1, 2024

Total Funding Raised

$19.98M

Company Overview

Resistell AG is a medtech company developing a rapid antibiotic susceptibility testing (AST) platform using nanomotion technology to combat antimicrobial resistance.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotech Equipment, Precision Medicine, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales, Usage-Based SaaS, Government Contracts

AI Layer

Application

Keywords

antibiotic susceptibility testingASTrapid ASTnanomotion technologyphenotypic ASTantimicrobial resistanceAMRsepsis diagnosticssuperbug detectiongrowth-independent diagnosticsmachine learning diagnosticsin vitro diagnosticsbloodstream infection diagnosticsdiagnostic consumableshigh-throughput diagnostics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Resistell AG Comparables

Compare Resistell AG with similar companies based on industry and business-model similarity.

Resistell AG comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
SoundCell B.V.
92%
PhAST Diagnostics
88%
Biolumo Sp. z o.o.
88%

Resistell AG Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJan 1, 2024
Series BDec 19, 2022
GrantJul 3, 2020
Series ADec 17, 2019
GrantJul 1, 2019
Seed
Dec 9, 2018

Key People

Founding team and executive leadership

Danuta Cichocka

Co-Founder & CEO

Founding Team

Martin Birk

Fractional CFO

Executive Team

Grzegorz Gonciarz

Chief Operating Officer

Executive Team

Resistell AG Investors

Notable investors and investment history

Resistell AG investors
InvestorRounds
European Innovation Council FundGrant
Launchpad Venture GroupSeries B
TRUMPF VentureSeries B, Series A
Alpana VenturesSeries A
InnosuisseGrant
OCCIDENTSeries B, Series A, Seed
Zurcher KantonalbankSeries B, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 21, 2026

    Monthly visitors increased 142% MoM.

  • Jan 5, 2026

    Monthly visitors increased 125% MoM.

Resistell AG Filings

Explore SEC and related filing metadata, where available.

Resistell AG filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Resistell AG's valuation, stock price, and market status.

Is Resistell AG a public or private company?

Resistell AG is a private company.

What is the current stock price of Resistell AG?

Resistell AG is a private company, so its shares have no public market price. Caplight tracks Resistell AG's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Resistell AG worth (valuation)?

Valuation information for Resistell AG is not publicly available.

Can I buy Resistell AG stock?

Resistell AG shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Resistell AG's last funding round?

Resistell AG's most recent funding round was Grant on January 1, 2024.

Who are the main investors in Resistell AG?

Key investors in Resistell AG include OCCIDENT.

Will Resistell AG IPO soon?

No public IPO plans have been announced for Resistell AG.

How can I track Resistell AG secondary market activity?

Caplight tracks bids, offers, and trades in Resistell AG's shares on secondary markets.

Firmographic Details

HeadquartersMuttenz
Employee Range19
Year Founded2018
Last FundingJan 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?